Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV001257581 | SCV001434390 | pathogenic | Vissers-Bodmer syndrome | 2020-09-29 | no assertion criteria provided | literature only | |
Clinical Genomics Laboratory, |
RCV001257581 | SCV004101382 | uncertain significance | Vissers-Bodmer syndrome | 2020-12-07 | no assertion criteria provided | clinical testing | The p.Arg1473Cys variant in the CNOT1 gene has been previously reported de novo in 1 individual with Vissers-Bodmersyndrome (Vissers et al., 2020). The p.Arg1473Cys variant has been identified in 1/113,550 European chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). The CNOT1 gene has fewer missense variants in the general population than expected. A low rate of missense variation may suggest that this gene is intolerant to missense variation. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Arg1473Cys variant is uncertain; however, there is suspicion that this variant could be associated with Vissers-Bodmer syndrome due to this variant being identified de novo in a published individual with features consistent with Vissers-Bodmer syndrome. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PM2;PP2] |